I giapponesi di Agc l'anciano un'Opa su Molmed e il titolo corre in borsa
Antioxidants | Free Full-Text | Cellular Aging Characteristics and Their Association with Age-Related Disorders
Will MolMed soon have its first Cell therapy on the Market?
Ultime Notizie Molmed News
Innovazione, la Borsa corre con plastica e super batteri - Corriere.it
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text
1 - [Note: this notice is the English translation of the official version of the 102 notice which will be in Italian language]
Press release issued by MolMed S.p.A. upon request of AGC Inc. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART
MolMed, viaggio nell'officina dei superfarmaci per le terapie geniche - Il Sole 24 ORE
Molmed, Opa dei giapponesi di Agc. Per Berlusconi 30 milioni di plusvalenza - Affaritaliani.it
Will MolMed soon have its first Cell therapy on the Market?
Aptamer-Based Antibacterial and Antiviral Therapy against Infectious Diseases | Journal of Medicinal Chemistry
Molmed, la giapponese Agc supera il 50% in Opa - Il Sole 24 ORE
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text
Azioni MolMed: Quotazione, Andamento e Previsioni | Emanuele Perini
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER
MolMed now part of AGC Biologics | LinkedIn
L'ok Ue fa volare Molmed (+11%) - MilanoFinanza.it
Press release issued by MolMed S.p.A. at the request of AGC Inc. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PA
MolMed - YouTube
Il 2019 è l'anno della svolta per MolMed - MilanoFinanza.it
MolMed: AIFA approva commercializzazione Zalmoxis. Titolo vola in Borsa - Economia e Finanza - Repubblica.it
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text
Molmed, l'Opa giapponese in bilico per golden power - ilGiornale.it
